Rayssa Gabriely Duarte Torres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rayssa Gabriely Duarte Torres has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Marcelo Duzzioni
Instituto de Ciências Biológicas e da Saúde
2 shared publications - Alexandre Urban Borbely
Institute of Biological and Health Sciences, Federal University of Alagoas, Maceió, Alagoas, Brazil
1 shared publication - Amanda Larissa Dias Pacheco
Institute of Biological Sciences and Health, Federal University of Alagoas (UFAL), Maceió, Brazil
1 shared publication - Amanda de Barros Coutinho
Institute of Biological Sciences and Health, Federal University of Alagoas (UFAL), Maceió, Brazil
1 shared publication - Ana Catarina Rezende Leite
Institute of Chemistry and Biotechnology, Federal University of Alagoas (UFAL), Alagoas, Brazil
1 shared publication - Bianca Rodrigues Melo da Silva
Institute of Biological Sciences and Health, Federal University of Alagoas (UFAL)
1 shared publication
Latest Publications
- 16 May 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (9) , 12164-12183
Ontogenic, Immunological, and Behavioral Changes of Crack Cocaine Exposure During the Gestational Period
Crack cocaine has a high addictive power that stimulates the central nervous system (CNS), and its high consumption by women of reproductive age has generated many challenges for public health. Crack cocaine use by pregnant women has been correlated with CNS malformations, cell damage, and changes in the immune system. Our purpose was to evaluate the effects of gestational exposure to crack cocaine in pregnant rats on ectoplacental cone cells, immune organs, maternal behavior, anxiety-like phenotype, metabolites, and sensorimotor reflex development of offspring. Pregnant rats were exposed to air or crack cocaine (200 mg) from the 5th gestational day (5thGD) to the 9th GD or until the end of pregnancy. Our findings showed that gestational exposure to crack cocaine increased trophoblast cell death, associated with reduced ectoplacental cone outgrowth in vitro. Furthermore, anxiogenic-like behavior in pregnant rats and negligence in maternal care were observed after exposure to crack cocaine. The development of motor reflexes in the offspring remained unchanged. In addition, exposure to crack cocaine during pregnancy reduced the relative weight of the spleen and CD8 + T lymphocyte subsets. No changes were observed in the thymus. Finally, we observed a series of changes in the metabolites of lactating rats exposed to crack cocaine during pregnancy. Taken together, our findings provide new insight into gestational changes promoted following exposure to crack cocaine and support future clinical interventions and treatments.
- 16 May 2025
- Published by Springer Nature in Molecular Neurobiology
- Vol. 62 (9) , 12164-12183
Ontogenic, Immunological, and Behavioral Changes of Crack Cocaine Exposure During the Gestational Period
Crack cocaine has a high addictive power that stimulates the central nervous system (CNS), and its high consumption by women of reproductive age has generated many challenges for public health. Crack cocaine use by pregnant women has been correlated with CNS malformations, cell damage, and changes in the immune system. Our purpose was to evaluate the effects of gestational exposure to crack cocaine in pregnant rats on ectoplacental cone cells, immune organs, maternal behavior, anxiety-like phenotype, metabolites, and sensorimotor reflex development of offspring. Pregnant rats were exposed to air or crack cocaine (200 mg) from the 5th gestational day (5thGD) to the 9th GD or until the end of pregnancy. Our findings showed that gestational exposure to crack cocaine increased trophoblast cell death, associated with reduced ectoplacental cone outgrowth in vitro. Furthermore, anxiogenic-like behavior in pregnant rats and negligence in maternal care were observed after exposure to crack cocaine. The development of motor reflexes in the offspring remained unchanged. In addition, exposure to crack cocaine during pregnancy reduced the relative weight of the spleen and CD8 + T lymphocyte subsets. No changes were observed in the thymus. Finally, we observed a series of changes in the metabolites of lactating rats exposed to crack cocaine during pregnancy. Taken together, our findings provide new insight into gestational changes promoted following exposure to crack cocaine and support future clinical interventions and treatments.
- Open Access
- 1 June 2024
- Published by KEAI Publishing in Non-coding RNA Research
- Vol. 9 (2) , 523-535
Systematic review and meta-analysis of dysregulated microRNAs derived from liquid biopsies as biomarkers for amyotrophic lateral sclerosis
The discovery of disease-specific biomarkers, such as microRNAs (miRNAs), holds the potential to transform the landscape of Amyotrophic Lateral Sclerosis (ALS) by facilitating timely diagnosis, monitoring treatment response, and accelerating drug discovery. Such advancement could ultimately improve the quality of life and survival rates for ALS patients. Despite more than a decade of research, no miRNA biomarker candidate has been translated into clinical practice. We conducted a systematic review and meta-analysis to quantitatively synthesize data from original studies that analyzed miRNA expression from liquid biopsies via PCR and compared them to healthy controls. Our analysis encompasses 807 miRNA observations from 31 studies, stratified according to their source tissue. We identified consistently dysregulated miRNAs in serum (hsa-miR-3665, -4530, -4745–5p, −206); blood (hsa-miR-338–3p, -183–5p); cerebrospinal fluid (hsa-miR-34a-3p); plasma (hsa-miR-206); and neural-enriched extracellular vesicles from plasma (hsa-miR-146a-5p, −151a-5p, −10b-5p, −29b-3p, and −4454). The meta-analyses provided further support for the upregulation of hsa-miR-206, hsa-miR-338–3p, hsa-miR-146a-5p and hsa-miR-151a-5p, and downregulation of hsa-miR-183–5p, hsa-miR-10b-5p, hsa-miR-29b-3p, and hsa-miR-4454 as consistent indicators of ALS across independent studies. Our findings provide valuable insights into the current understanding of miRNAs' dysregulated expression in ALS patients and on the researchers’ choices of methodology. This work contributes to the ongoing efforts towards discovering disease-specific biomarkers.
- 1 June 2024
- Published by KEAI Publishing in Non-coding RNA Research
- Vol. 9 (2) , 523-535
Open AccessSystematic review and meta-analysis of dysregulated microRNAs derived from liquid biopsies as biomarkers for amyotrophic lateral sclerosis
The discovery of disease-specific biomarkers, such as microRNAs (miRNAs), holds the potential to transform the landscape of Amyotrophic Lateral Sclerosis (ALS) by facilitating timely diagnosis, monitoring treatment response, and accelerating drug discovery. Such advancement could ultimately improve the quality of life and survival rates for ALS patients. Despite more than a decade of research, no miRNA biomarker candidate has been translated into clinical practice. We conducted a systematic review and meta-analysis to quantitatively synthesize data from original studies that analyzed miRNA expression from liquid biopsies via PCR and compared them to healthy controls. Our analysis encompasses 807 miRNA observations from 31 studies, stratified according to their source tissue. We identified consistently dysregulated miRNAs in serum (hsa-miR-3665, -4530, -4745–5p, −206); blood (hsa-miR-338–3p, -183–5p); cerebrospinal fluid (hsa-miR-34a-3p); plasma (hsa-miR-206); and neural-enriched extracellular vesicles from plasma (hsa-miR-146a-5p, −151a-5p, −10b-5p, −29b-3p, and −4454). The meta-analyses provided further support for the upregulation of hsa-miR-206, hsa-miR-338–3p, hsa-miR-146a-5p and hsa-miR-151a-5p, and downregulation of hsa-miR-183–5p, hsa-miR-10b-5p, hsa-miR-29b-3p, and hsa-miR-4454 as consistent indicators of ALS across independent studies. Our findings provide valuable insights into the current understanding of miRNAs' dysregulated expression in ALS patients and on the researchers’ choices of methodology. This work contributes to the ongoing efforts towards discovering disease-specific biomarkers.